246 related articles for article (PubMed ID: 14601962)
1. Effect of fill weight, capsule shell, and sinker design on the dissolution behavior of capsule formulations of a weak acid drug candidate BMS-309403.
Wu Y; Zhao F; Paborji M
Pharm Dev Technol; 2003; 8(4):379-83. PubMed ID: 14601962
[TBL] [Abstract][Full Text] [Related]
2. The in vitro dissolution of theophylline from different types of hard shell capsules.
Podczeck F; Jones BE
Drug Dev Ind Pharm; 2002 Oct; 28(9):1163-9. PubMed ID: 12455475
[TBL] [Abstract][Full Text] [Related]
3. Performance qualification of a new hypromellose capsule: part I. Comparative evaluation of physical, mechanical and processability quality attributes of Vcaps Plus, Quali-V and gelatin capsules.
Sherry Ku M; Li W; Dulin W; Donahue F; Cade D; Benameur H; Hutchison K
Int J Pharm; 2010 Feb; 386(1-2):30-41. PubMed ID: 19900518
[TBL] [Abstract][Full Text] [Related]
4. HPMC capsules: current status and future prospects.
Al-Tabakha MM
J Pharm Pharm Sci; 2010; 13(3):428-42. PubMed ID: 21092714
[TBL] [Abstract][Full Text] [Related]
5. The shell dissolution of various empty hard capsules.
Chiwele I; Jones BE; Podczeck F
Chem Pharm Bull (Tokyo); 2000 Jul; 48(7):951-6. PubMed ID: 10923822
[TBL] [Abstract][Full Text] [Related]
6. Stabilization of hard gelatin capsule shells filled with polyethylene glycol matrices.
Stein D; Bindra DS
Pharm Dev Technol; 2007; 12(1):71-7. PubMed ID: 17484146
[TBL] [Abstract][Full Text] [Related]
7. Time domain 1H NMR as a new method to monitor softening of gelatin and HPMC capsule shells.
Kuentz M; Rothenhäusler B; Röthlisberger D
Drug Dev Ind Pharm; 2006; 32(10):1165-73. PubMed ID: 17090439
[TBL] [Abstract][Full Text] [Related]
8. Influence of capsule shell composition on the performance indicators of hypromellose capsule in comparison to hard gelatin capsules.
Al-Tabakha MM; Arida AI; Fahelelbom KM; Sadek B; Saeed DA; Abu Jarad RA; Jawadi J
Drug Dev Ind Pharm; 2015; 41(10):1726-37. PubMed ID: 25586554
[TBL] [Abstract][Full Text] [Related]
9. Hard gelatin and hypromellose (HPMC) capsules: estimation of rupture time by real-time dissolution spectroscopy.
El-Malah Y; Nazzal S; Bottom CB
Drug Dev Ind Pharm; 2007 Jan; 33(1):27-34. PubMed ID: 17192248
[TBL] [Abstract][Full Text] [Related]
10. Performance qualification of a new hypromellose capsule: Part II. Disintegration and dissolution comparison between two types of hypromellose capsules.
Ku MS; Lu Q; Li W; Chen Y
Int J Pharm; 2011 Sep; 416(1):16-24. PubMed ID: 21356291
[TBL] [Abstract][Full Text] [Related]
11. 3D Printing and Dissolution Testing of Novel Capsule Shells for Use in Delivering Acetaminophen.
Gaurkhede SG; Osipitan OO; Dromgoole G; Spencer SA; Pasqua AJD; Deng J
J Pharm Sci; 2021 Dec; 110(12):3829-3837. PubMed ID: 34469748
[TBL] [Abstract][Full Text] [Related]
12. Gelatin and Non-Gelatin Capsule Dosage Forms.
Gullapalli RP; Mazzitelli CL
J Pharm Sci; 2017 Jun; 106(6):1453-1465. PubMed ID: 28209365
[TBL] [Abstract][Full Text] [Related]
13. Predicting the human in vivo performance of different oral capsule shell types using a novel in vitro dynamic gastric model.
Vardakou M; Mercuri A; Naylor TA; Rizzo D; Butler JM; Connolly PC; Wickham MS; Faulks RM
Int J Pharm; 2011 Oct; 419(1-2):192-9. PubMed ID: 21843611
[TBL] [Abstract][Full Text] [Related]
14. Achieving gastroresistance without coating: Formulation of capsule shells from enteric polymers.
Barbosa JAC; Al-Kauraishi MM; Smith AM; Conway BR; Merchant HA
Eur J Pharm Biopharm; 2019 Nov; 144():174-179. PubMed ID: 31541663
[TBL] [Abstract][Full Text] [Related]
15. Bioavailability and in vitro oesophageal sticking tendency of hydroxypropyl methylcellulose capsule formulations and corresponding gelatine capsule formulations.
Honkanen O; Laaksonen P; Marvola J; Eerikäinen S; Tuominen R; Marvola M
Eur J Pharm Sci; 2002 Jun; 15(5):479-88. PubMed ID: 12036724
[TBL] [Abstract][Full Text] [Related]
16. Effects of food on a gastrically degraded drug: azithromycin fast-dissolving gelatin capsules and HPMC capsules.
Curatolo W; Liu P; Johnson BA; Hausberger A; Quan E; Vendola T; Vatsaraj N; Foulds G; Vincent J; Chandra R
Pharm Res; 2011 Jul; 28(7):1531-9. PubMed ID: 21331473
[TBL] [Abstract][Full Text] [Related]
17. Investigations into the use of pregelatinised starch to develop powder-filled hard capsules.
Gohil UC; Podczeck F; Turnbull N
Int J Pharm; 2004 Nov; 285(1-2):51-63. PubMed ID: 15488679
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo pharmacoscintigraphic evaluation of ibuprofen hypromellose and gelatin capsules.
Cole ET; Scott RA; Cade D; Connor AL; Wilding IR
Pharm Res; 2004 May; 21(5):793-8. PubMed ID: 15180336
[TBL] [Abstract][Full Text] [Related]
19. Development of novel spray coated soft elastic gelatin capsule sustained release formulations of nifedipine.
Abd El-Sattar Fahmy S; Christensen JM; Ayres JW
Drug Dev Ind Pharm; 2009 Aug; 35(8):1009-21. PubMed ID: 19274589
[TBL] [Abstract][Full Text] [Related]
20. Effect of sodium lauryl sulfate in dissolution media on dissolution of hard gelatin capsule shells.
Zhao F; Malayev V; Rao V; Hussain M
Pharm Res; 2004 Jan; 21(1):144-8. PubMed ID: 14984269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
